ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0250

Is There a Need for a New Classification Criteria in Juvenile Spondyloarthritis?

Maria Martha Katsicas1, Maria Cecilia Bertinotti2 and Maria Giselle Villarreal2, 1Hospital de Pediatria J.P Garrahan, Buenos Aires, Argentina, 2Garrahan, Buenos Aires, Argentina

Meeting: ACR Convergence 2021

Keywords: classification criteria, juvenile, Spondyloarthropathies

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 6, 2021

Title: Pediatric Rheumatology – Clinical Poster I: JIA (0241–0265)

Session Type: Poster Session A

Session Time: 8:30AM-10:30AM

Background/Purpose: Juvenile SpA (JSpA) involve enthesitis related arthritis (ERA), juvenile psoriatic arthritis and undifferentiated arthritis (UA) according to the ILAR criteria. Two different patterns have been found: axial and peripheral. The pediatric form differs from that in adults by a predominant peripheral involvement. The evolution to ankylosis has been reported in one third of all cases after several years. The proposed PRINTO classification criteria for JIA introduced a new approach changing ERA to enthesitis/spondylitis-related JIA (ESRA) resulting in a definition harmonized with that for adults. The purposes were to assess the sensibility and specificity of the provisional new PRINTO JIA classification criteria for ESRA and to compare its performance to others adult´s classification criteria. To identify predictive variables for ankylosis progression.

Methods: Consecutive patients with JSpA (defined as ERA or UA according to ILAR) followed in our center were included. Randomly selected patients with oligoarthritis (23), polyarthritis RF negative (22) and systemic (20) served as controls. Variables recorded included: arthritis, enthesitis, tarsitis, inflammatory back pain (IBP), SI- joint tenderness, presence of HLA-B27 antigen, acute anterior uveitis, history of SpA in a first-degree relative. Imaging on SI-joints (SI joints) on X-ray and/or MRI. Classification criteria for adults were ASAS and Modified New York (NY). Patients with ankylosing progression fulfilled NY criteria. Summary statistics: sensitivity, specificity, positive predictive value (PPV), negative predictive value (NVP), positive Likelihood ratio (+LR) and negative Likelihood ratio (-LR). Univariate and multivariate logistic regression for predictors variables.

Results: 112 patients with JSpA (89 ERA, 23 UA) were included (M: 94), median age at onset: 10 (1-15) years, disease duration at time of first visit 8.5 (1-48) months, follow-up 7 (1-15) years. Controls: 65 JIA (M: 27). At first visit showed: 107 (95%) arthritis, 69 (62%) elevated CRP, 54 (48%) limitation of lumbar spine motion, 56 (50%) HLA-B27, 48(43%) enthesitis, 44 (40%) tarsitis, 42 (37%) IBP, 31 (30%) SI- joint tenderness, 30 (27%) good response to NSAIDS, 26 (23%) positive family history, 12 (10%) dactylitis, 7(6%) uveitis,7(6%) diarrhea, 5(5 %) infectious previous, 2(2%) urethritis, 2(2%) IBD, 2 (2%) buttock pain. Imaging for sacroiliitis: 30 (27%) on X-Ray (23 grade 2 bilateral and 7 grade 3), 26 (23%) on MRI. At first visit (112 patients): 95 (87%) fulfilled ESRA criteria. Disease course (102 patients): 97 (95%). Patients who meet NY criteria: 64 (63%). Table 1 shows the accuracy for classification criteria. The unique predictor variable for ankylosing progression was lumbar limitation (p=0.02). Table 2 shows the accuracy of the selected variables at onset of the disease for predicting the risk of developing JAS.

Conclusion: The new proposed PRINTO criteria was a more sensitive classification criteria than adults’ criteria. Lumbar limitation was a predictor variable for ankylosing. The accuracy of each selected variable at onset suggests the probability of a higher suspected index for JSpA.

*on imaging


Disclosures: M. Katsicas, Novartis, 4, Pfizer, 6; M. Bertinotti, None; M. Villarreal, None.

To cite this abstract in AMA style:

Katsicas M, Bertinotti M, Villarreal M. Is There a Need for a New Classification Criteria in Juvenile Spondyloarthritis? [abstract]. Arthritis Rheumatol. 2021; 73 (suppl 9). https://acrabstracts.org/abstract/is-there-a-need-for-a-new-classification-criteria-in-juvenile-spondyloarthritis/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2021

ACR Meeting Abstracts - https://acrabstracts.org/abstract/is-there-a-need-for-a-new-classification-criteria-in-juvenile-spondyloarthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology